Sleeping Bruxism Treatment Market Overview
Sleep bruxism is a condition in which the patient grinds his teeth while sleeping. Bruxism is a type of bruxism that occurs during the day. However, it can also happen inadvertently while sleeping. Because the patient is unconscious at the time, the condition of sleep bruxism is more problematic. During such instances, the patient exerts a great deal of power on his teeth and jaw. The teeth and jaw are severely damaged as a result of this. The patient is unable to manage the amount of force he applies to his teeth and jaw. As a result, treating the symptoms of sleep bruxism becomes required. The Sleeping Bruxism Treatment Industry is concerned with a variety of treatment and care options for sleep bruxism recovery.
On a global basis, the rising prevalence of sleep bruxism is a major market driver. The Market's application range expands as a result of the prevalence. Another market driver is the rise in stress levels among people. With the fast pace of life and the threat of a pandemic, the market for Sleeping Bruxism Treatment has an opportunity to grow. There are certain limitations in the Sleeping Bruxism Therapy Market, such as the lack of treatment choices. The Sleeping Bruxism Treatment Industry's growth is hampered by a lack of research and development in the market. As a result, the market must concentrate more on producing more complex treatment solutions. For the future, the key players of the Sleeping Bruxism Treatment Industry must contribute. Market growth will be stifled if research and development is not prioritized.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Diagnosis, Treatment, Cause, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Ivoclar Vivadent AG, Ipsen Biopharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Akervall Technologies Inc., PLANMECA OY, Randmark Dental Products, LLC, MAC Thin Films , ICOAT COMPANY, LLC, Janos Tech. |
Covid-19 Impact on Sleeping Bruxism Treatment Market
In addition, the current Sleeping Bruxism Treatment Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Sleeping Bruxism Treatment Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Sleeping Bruxism Treatment Market Segment Overview
According to Type, Primary Bruxism is one of the most important segments in the market. Primary bruxism is further divided into two types: awake and sleep bruxism. Clenching or grinding of the teeth is a common activity that can occur both during the day and at night. Awake bruxism happens during the day with clenching being more prominent. It is defined as awareness of jaw clenching and appears to be semi-voluntary. Sleep bruxism occurs at night while sleeping with grinding being more prominent. It is defined as a sleep-related movement and is involuntary.
Sleeping Bruxism Treatment Market, By Type
· Primary Bruxism
· Secondary Bruxism
Sleeping Bruxism Treatment Market, By Diagnosis
· Clinical Examination
· Polysomnography
Sleeping Bruxism Treatment Market, By Treatment
· Dental Approaches
· Treatment Drugs
Sleeping Bruxism Treatment Market, By Cause
· Obstructive Sleep Apnea
· GERD
· Malocclusion
· Sleep Paralysis
Sleeping Bruxism Treatment Market Regional Overview
Geographically, according to the Sleeping Bruxism Treatment Market Outlook, North America holds the majority of the market share. The European region is expected to be the fastest expanding regional market for Sleeping Bruxism Treatment, according to market trends. Due to the huge population, the regional markets of the Asia Pacific and the Middle East will also see significant expansion. However, due to a lack of health awareness in the region, the African regional market would experience the slowest development.
Sleeping Bruxism Treatment Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Sleeping Bruxism Treatment Market, Key Players
· Ivoclar Vivadent AG
· Ipsen Biopharmaceuticals, Inc.
· Merz Pharma GmbH & Co. KGaA
· Carestream Dental
· Akervall Technologies Inc.
· PLANMECA OY
· Randmark Dental Products, LLC
· MAC Thin Films
· ICOAT COMPANY, LLC
· Janos Tech
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the Sleeping Bruxism Treatment market?
The rising prevalence of sleep bruxism is a major market driver
Q2. What are the restraining factors for the Sleeping Bruxism Treatment market?
There are certain limitations in the Sleeping Bruxism Therapy market, such as the lack of treatment choices.
Q3. Which segment is projected to hold the largest share in the Sleeping Bruxism Treatment Market?
Primary Bruxism segment is projected to hold the largest share in the Sleeping Bruxism Treatment Market.
Q4. Which region holds the largest share in the Sleeping Bruxism Treatment market?
North America held the largest share in the global Sleeping Bruxism Treatment market
Q5. Which are the prominent players in the Sleeping Bruxism Treatment Market?
Ivoclar Vivadent AG, Ipsen Biopharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Akervall Technologies Inc., PLANMECA OY, Randmark Dental Products, LLC, MAC Thin Films , ICOAT COMPANY, LLC, Janos Tech. are some key players in the Sleeping Bruxism Treatment Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Sleeping Bruxism Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Primary Bruxism
- 5.2.2. Secondary Bruxism
- 5.3. Market Analysis, Insights and Forecast – By Diagnosis
- 5.3.1. Clinical Examination
- 5.3.2. Polysomnography
- 5.4. Market Analysis, Insights and Forecast – By Treatment
- 5.4.1. Dental Approaches
- 5.4.2. Treatment Drugs
- 5.5. Market Analysis, Insights and Forecast – By Cause
- 5.5.1. Obstructive Sleep Apnea
- 5.5.2. GERD
- 5.5.3. Malocclusion
- 5.5.4. Sleep Paralysis
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America, Middle East and Africa
6. North America Sleeping Bruxism Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Primary Bruxism
- 6.2.2. Secondary Bruxism
- 6.3. Market Analysis, Insights and Forecast – By Diagnosis
- 6.3.1. Clinical Examination
- 6.3.2. Polysomnography
- 6.4. Market Analysis, Insights and Forecast – By Treatment
- 6.4.1. Dental Approaches
- 6.4.2. Treatment Drugs
- 6.5. Market Analysis, Insights and Forecast – By Cause
- 6.5.1. Obstructive Sleep Apnea
- 6.5.2. GERD
- 6.5.3. Malocclusion
- 6.5.4. Sleep Paralysis
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Sleeping Bruxism Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Primary Bruxism
- 7.2.2. Secondary Bruxism
- 7.3. Market Analysis, Insights and Forecast – By Diagnosis
- 7.3.1. Clinical Examination
- 7.3.2. Polysomnography
- 7.4. Market Analysis, Insights and Forecast – By Treatment
- 7.4.1. Dental Approaches
- 7.4.2. Treatment Drugs
- 7.5. Market Analysis, Insights and Forecast – By Cause
- 7.5.1. Obstructive Sleep Apnea
- 7.5.2. GERD
- 7.5.3. Malocclusion
- 7.5.4. Sleep Paralysis
- 7.6. Market Analysis, Insights and Forecast – By Country
- 7.6.1. UK
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Russia
- 7.6.7. Rest of Europe
8. Asia Pacific Sleeping Bruxism Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Primary Bruxism
- 8.2.2. Secondary Bruxism
- 8.3. Market Analysis, Insights and Forecast – By Diagnosis
- 8.3.1. Clinical Examination
- 8.3.2. Polysomnography
- 8.4. Market Analysis, Insights and Forecast – By Treatment
- 8.4.1. Dental Approaches
- 8.4.2. Treatment Drugs
- 8.5. Market Analysis, Insights and Forecast – By Cause
- 8.5.1. Obstructive Sleep Apnea
- 8.5.2. GERD
- 8.5.3. Malocclusion
- 8.5.4. Sleep Paralysis
- 8.6. Market Analysis, Insights and Forecast – By Country
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. Australia
- 8.6.5. South East Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Sleeping Bruxism Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Primary Bruxism
- 9.2.2. Secondary Bruxism
- 9.3. Market Analysis, Insights and Forecast – By Diagnosis
- 9.3.1. Clinical Examination
- 9.3.2. Polysomnography
- 9.4. Market Analysis, Insights and Forecast – By Treatment
- 9.4.1. Dental Approaches
- 9.4.2. Treatment Drugs
- 9.5. Market Analysis, Insights and Forecast – By Cause
- 9.5.1. Obstructive Sleep Apnea
- 9.5.2. GERD
- 9.5.3. Malocclusion
- 9.5.4. Sleep Paralysis
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. Brazil
- 9.6.2. Saudi Arabia
- 9.6.3. UAE
- 9.6.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Ivoclar Vivadent AG
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Ipsen Biopharmaceuticals, Inc.
- 10.6. Merz Pharma GmbH & Co. KGaA
- 10.7. Carestream Dental
- 10.8. Akervall Technologies Inc.
- 10.9. PLANMECA OY
- 10.10. Randmark Dental Products, LLC
- 10.11. MAC Thin Films
- 10.12. ICOAT COMPANY, LLC
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
